While RNA vaccine development has been in the spotlight since the Corona-19 outbreak, RSVI-301, RosVivo’s new drug pipeline for diabetes, also uses miRNA (micro-RNA)....
The results of the SURPASS-2 clinical trial evaluating the effects of tirzepatide in patients with type 2 diabetes showed that the trial treatment resulted...
OUTA new study, supported by the National Institutes of Health, aims to improve the screening and diagnosis of gestational diabetes through a better understanding...